Nob3 is a major obesity quantitative trait locus (QTL) identified in an intercross of New Zealand Obese (NZO) mice with C57BL/6J (B6), and by introgression of its 38 Mbp peak region into B6 (B6.NZO-Nob3.38). B6.NZONob3.38 mice carrying the NZO allele exhibited markedly increased body weight, fat mass, lean mass and a lower energy expenditure, than the corresponding B6 allele carriers. For positional cloning of the responsible obesity gene, five additional congenic lines (RCS) were generated and characterized, allowing to define a critical genomic interval comprising 43 genes. mRNA profiling and western blotting indicated that Ifi202b, a member of the Ifi200 family of interferon inducible transcriptional modulators, was expressed in NZO-allele carriers but was undetectable in tissues of homozygous B6-allele carriers due to a microdeletion, including the first exon and the 5 ′ -flanking region of Ifi202b in B6. Transcriptome analysis of adipose tissue of RCS revealed a marked induction of 11b-hydroxysteroid dehydrogenase type 1 (11b-Hsd1) expression in mice expressing Ifi202b. Furthermore, siRNA-mediated Ifi202b suppression in 3T3-L1 adipocytes resulted in a significant inhibition of 11b-Hsd1 expression, whereas an adenoviral-mediated overexpression of Ifi202b increased 11b-Hsd1 mRNA levels. Expression of human IFI orthologues was significantly increased in visceral adipose tissue of obese subjects. We suggest that the disruption of Ifi202b in B6 is responsible for the effects of the obesity QTL Nob3, and that Ifi202b modulates fat accumulation through expression of adipogenic genes such as 11b-Hsd1.
INTRODUCTION
Obesity is a complex disease based on the combination of multiple genes and their interaction with the environment (1,2). Genome-wide association studies have identified common single nucleotide polymorphisms (SNPs) associated with increased body mass index (BMI) such as FTO, MC4R, BDNF and SH2B1 genes (3 -6) . However, together these polymorphisms account for a small percentage of the inherited variation in body weight indicating that a substantial proportion of the heritable component of the disease remains to be explained.
Genetic linkage and association studies are additional approaches to associate gene loci with physiological traits like obesity. Numerous quantitative trait loci (QTL) reflecting broad genomic regions influencing body weight have been mapped but the identification of the individual gene(s) responsible for the phenotype remains difficult. Consequently, only a few percent of the many QTL that have been mapped resulted in the identification of the underlying gene (7) .
The New Zealand Obese (NZO) mouse develops a polygenic disease pattern of obesity, insulin resistance and dyslipoproteinemia closely resembling the human metabolic syndrome * To whom correspondence should be addressed at: German Institute of Human Nutrition, Arthur-Scheunert-Allee 114-116, D-14558 Nuthetal, Germany. Tel: +49 33200882368; Fax: +49 33200882334; Email: schuermann@dife.de (8, 9) . In order to identify chromosomal segments associated with these traits, we performed genome-wide linkage analysis in a backcross population of the NZO and the Swiss Jim Lambert mouse and identified several QTL. By positional cloning, we have recently discovered two genes encoding the Rab-GAP protein TBC1D1 (10) and the transcription factor ZFP69 (11) that participate in the development of the metabolic syndrome. Furthermore, in an outcross population of NZO with the lean C57BL/6J (B6) mouse, we identified a major obesity QTL (Nob3) on distal mouse chromosome 1 (Chr. 1) with a LOD score of 16.1. This QTL is responsible for a difference in body weight of 13 g in week 22 . Introgression of a 38 Mbp fragment (Nob3.38)-corresponding with the distal peak of the QTL-from NZO into the B6 background increased body weight significantly (12) .
In the present study, we define a critical genomic interval of 2.2 Mbp within Nob3.38 which influences body weight. We furthermore identify a B6-specific microdeletion disrupting expression of Ifi202b which modifies the expression of 11b-Hsd1 in adipose tissue, presumably protecting the B6 mouse from the development of severe obesity. We furthermore show that the corresponding human orthologues exhibit an altered expression in the visceral adipose tissue of obese subjects.
RESULTS

Identification of a critical region of Nob3.38 with a series of recombinant congenic lines
Introgression of a 38 Mbp segment of the previously described QTL Nob3 (12) from NZO into B6 (B6.NZO-Nob3.38; Fig. 1A ) markedly increased body weight, fat mass and lean mass of male and female congenic mice kept on a high-fat diet (Fig. 1B) . Histology of white adipose tissue indicated that adipocytes of NZO-allele carriers were much larger than those of the corresponding B6-allele carriers (Supplementary Material, Fig. S1 ). This effect was associated with elevated mRNA levels for leptin (B6. N/N : 3.08 + 0.6; B6.NZO-Nob3.38 B/B : 1.34 + 0.32 relative expression; P , 0.005). Furthermore, energy expenditure (EE) was significantly reduced in carriers of the NZO allele (Fig. 1C, left panel) , consistent with the previously described reduction in rectal body temperature of parental NZO mice (8) and the Nob3.38 NZO-allele carriers (12) (B6. N/N : 37.2 + 0.18C; B6.NZO-Nob3.38 B/B : 37.6 + 0.18C; P , 0.005). In contrast, locomotor activity and food intake did not differ between B6. N/N and B6.NZO-Nob3.38 B/B mice (Fig. 1C , middle and right panels, respectively). Thus, the difference in adiposity mediated by Nob3 is associated with an altered thermogenesis which could be responsible for decreased total EE.
In order to define a critical segment of Nob3.38 by a conventional strategy of positional cloning, additional congenic lines carrying different segments of Nob3.38 ( Fig. 2A) were generated and characterized with regard to their increment of body weight. Segments IV to VI were adipogenic, whereas segments VII and VIII (Fig. 2B ) failed to increase body weights. Thus, the critical interval of Nob3.38 on Chr. 1 comprising the adipogenic allele was convincingly defined by the markers D1Mit522 and D1Mit403 between 175.3 and 177.6 Mbp (Fig. 1A) . For further fine mapping, we used SNPs and defined the borders of the critical interval of 2.2 Mbp (Fig. 2C ) flanked by Cadm3 and Rgs7. The interval comprises 14 genes encoding olfactory receptors, 1 transfer RNA, 7 pseudogenes, 4 gene models and 17 annotated genes, 7 of which belong to the Ifi200 cluster (Ifi202b, Ifi203, Ifi204, Ifi205, Mnda, Mndal and Aim2). In addition to the known Ifi200 genes, four other genes (Pydc4, Pyhin1, Pydc3, BC094916) and four gene models (EG240921, LOC623121, AI607873, EG666028) within the critical interval exhibit a significant similarity to Ifi200 genes, and comprise the N-terminal DAPIN/PYRIN motif and/or a HIN200 domain that characterizes the Ifi family. In order to identify the responsible gene variant, we (i) sequenced the area between 175.3 and 177. B/B mice. We next studied the expression of transcripts and gene models within the critical region by quantitative real-time -polymerase chain reaction (qRT-PCR) in more detail. As shown in Figure 3A , we could confirm that mRNA of Ifi202b was undetectable in tissues of B6.NZO-Nob3.38 B/B mice but expressed in B6. N/N mice. Expression of most genes belonging to the Ifi200 cluster (Aim2, EG240921, Pyhin1, Pydc3, Mndal, Ifi203, Ifi205) were significantly reduced in tissues of B6. N/N mice in comparison to carriers of the B6 allele (Fig. 3A, Supplementary Material, Fig. S2 ), whereas Pydc4, AI607873 and Ifi204 did not show differences. Because of the high homology between some transcripts of the Ifi200 cluster, it was impossible to design a unique probe for Mnda which would not also amplify other Ifi mRNAs.
We next tested the expression of Ifi202b in several tissues of the two parental strains NZO and B6. Highest levels of mRNA were determined in subcutaneous white adipose tissue and skeletal muscle of NZO mice, lower levels in gonadal white adipose tissue, brown adipose tissue, pancreas, and liver of NZO mice. Like in B6. B/B mice, we failed to detect Ifi202b mRNA in these tissues of B6 mice (Fig. 3B) . A search in the databases identified expressed sequence tags of Ifi202b in thymus, taste buds, mammary gland, skin and vagina from B6. Therefore, we confirmed by qRT -PCR that mRNA of Ifi202b is indeed detectable in taste buds of B6 mice (Fig. 3B) . However, as is shown below (Fig. 4) , this expression appears to be driven by a different promoter.
Antiserum against peptides corresponding with the Ifi202b sequence detected specific signals in lysates of liver, skeletal muscle and white adipose tissue of NZO mice, but no signal in tissues of B6 mice (Fig. 3C) protein is absent in skeletal muscle of B6-allele carriers but present in NZO-allele carriers (Fig. 3D) .
In order to test whether the additive effect of Nob3.38 on obesity corresponds with a similar effect of the locus on Ifi202b expression, we compared the Ifi202b expression in liver and white adipose tissue of heterozygous B6.NZO- 
Identification of a microdeletion disrupting the Ifi202b gene
In order to test the possibility that the striking difference in the Ifi202b expression between B6 and NZO allele carriers is the consequence of the formation of different mRNA species, we analysed the Ifi202b cDNA from taste buds (B6) and gonadal adipose tissue (NZO) by 5
′ RLM-RACE-PCR. With primers located in exon 3, we obtained 5
′ sequences which markedly differed between both strains. The sequence of the B6 tastebud mRNA was identical with that of the reference sequence (accession numbers: NM_008327, NM_011940). In contrast, the NZO-derived rapid amplification of cDNA-ends (RACE) product matched only partially to the reference sequence (exon 2), and appeared to be spliced to an alternative exon 1 (exon 1b). The variation in the genomic organization of the Ifi202b locus between B6 and NZO mice was confirmed by PCR on cDNA and genomic DNA. As shown in Figure 4 , primers corresponding to the first exon of B6 in combination with reverse primers on exon 2 (P2) or 3 (P1) amplified a PCR product only on B6 DNA, while the same reverse primers (P3, P4) in combination with primers of the NZO-specific first exon generated a PCR product on NZO DNA. The PCR on the genomic DNA indicated that the first intron of B6 Ifi202b has a size of 5 kb, that of NZO Ifi202b of 4 kb. Sequence analysis demonstrated that the homology between both intronic sequences stopped 970 bp upstream of exon 2, indicating that B6 mice carry a microdeletion of the 5 ′ -flanking region of Ifi202b, including its promoter, exon 1 and parts of the first intron. In taste buds, an alternative first exon (exon 1a) is spliced to exon 2, presumably driven by a different, taste-bud specific promoter (Fig. 4A) . Interestingly, we can amplify the alternative exon 1a also on the genomic DNA of the NZO mouse (data not shown), indicating that the deletion in the B6 genome is located between the alternative exon 1a and the first intron of Ifi202b as indicated in Figure 4A .
Ifi202b affects the expression of other genes within the Ifi200 cluster It has been described previously that alterations in Ifi200 expression result in the counterregulation of related Ifi transcripts (13) (14) (15) ). Thus, we tested whether the marked difference in Ifi202b expression is responsible for the increased expression of the other genes within this cluster (Fig. 3A) . Ifi202b was overexpressed in muscle of B6 mice by electroporation of myc-tagged Ifi202b (Fig. 5A ) and the expression of Aim2, Pyhin1, Pydc3, Ifi204, Mndal, Ifi203 and Ifi205 was determined. As expected, we detected a significantly lower expression of other Ifi200 genes in muscles that were transfected with the cDNA of Ifi202b than in those transfected with a vector encoding green fluorescent protein (GFP; Fig. 5B ). Overexpression of Ifi202b did not influence levels of Pcp41l, Dusp23 and Rgs5, three transcripts located in close proximity of the Ifi200 cluster but outside of the critical region (Fig. 5B ).
Ifi202b modifies expression of 11b-Hsd1
In order to identify a plausible biological mechanism linking Ifi202b expression in NZO mice with obesity, we studied the expression profiles of adipose tissues from B6.NZONob3.38 B/B and B6.NZO-Nob3.38 N/N mice in detail and screened altered genes in respect to their impact on body weight and the metabolic syndrome. Table 1 shows a list of 11 genes with the strongest differences in expression between NZO-and B6-allele carriers. One important transcript which exhibits highly and significantly elevated expression in WAT of NZO-allele carrier is 11b-Hsd1 (Table 1, Fig. 6A ). It drives lipid accumulation and adipocyte hypertrophy (16) (17) (18) (19) as well as insulin resistance (20) when its expression is elevated. We confirmed the array data by qRT -PCR on WAT of B6.NZO-Nob3.38
and B6. N/N mice (Fig. 6B) .
We next analyzed expression of Ifi202b in 3T3-L1 cells during differentiation. Ifi202b is expressed already in nonconfluent 3T3-L1 fibroblasts. However, its levels increase 2-3 fold when cells reach confluence (preadipocytes) and differentiation is initiated until day 4 before they drop to initial levels at the stage of mature adipocytes at day 7 after initiation of differentiation (Fig. 7A, upper panel) . In comparison, expression of Pref1 (Fig. 7A, middle panel) , an inhibitor of adipocyte differentiation was maximal in confluent preadipocytes and abolished during differentiation. We furthermore confirmed that 11b-Hsd1 expression is restricted to late stages of differentiation (20, 21) (Fig. 7A, lower panel) . Comparing Ifi202b and 11b-Hsd1 expression lead to the hypothesis that Ifi202b is required to induce 11b-Hsd1 expression. In order to test this, we suppressed Ifi202b in 3T3-L1 adipocytes by electroporating an Ifi202b-specific siRNA and determined mRNA levels of 11b-Hsd1. As shown in Figure 7B , depletion of Ifi202b specifically suppressed 11b-Hsd1 expression and upregulated mRNA levels of Pref1 (Fig. 7B) . On the other hand, 11b-Hsd1 mRNA levels increased after an adenovirusmediated overexpression of Ifi202b (Fig. 7C) . Similarly, overexpression of Ifi202b in tibialis muscle by electroporation increased 11b-Hsd1 expression (in Ifi202b transfected: 0.0113 + 0.00065 versus GFP transfected control: 0.0097 + 0.00061 level of expression in comparison to that of b-actin; P ¼ 0.0276).
Altered mRNA levels of human IFI genes in white adipose tissue of obese individuals
In order to test whether the expression of Ifi genes is altered in human obesity, we determined their mRNA levels in visceral white adipose tissue of 53 lean (BMI , 25) and 221 obese (BMI . 30) individuals. The human syntenic region on Chr. 1 contains only four Ifi genes, AIM2, IFI16, PYHIN and MNDA (Fig. 8A) . As illustrated in Figure 8B , mRNA levels of IFI16 and MNDA were significantly higher in visceral adipose tissue of obese than in lean individuals (Fig. 8B ). In addition, there was a significant correlation of maximal visceral fat cell size with IFI16 (r ¼ 0.509; P ¼ 0.002) and MNDA mRNA (r ¼ 0.504; P ¼ 0.002). In contrast, mRNA levels of PYHIN1 were significantly lower in adipose tissue of obese subjects (Fig. 8B) .
DISCUSSION
The present data identify a microdeletion disrupting the transcriptional regulator Ifi202b on distal Chr. 1 of C57BL/6J mice as the most likely molecular cause for the antiadipogenic effect of the B6 allele of mouse QTL Nob3. The following arguments lead to this conclusion: (i) with intervalspecific congenics, we defined a critical genomic interval with 43 genes that were crucial to increase body weight. (ii) The most pronounced allelic variation was a microdeletion which includes the promoter and the first exon of Ifi202b. (iii) In NZO Ifi202b protein is most abundant in adipose tissue, and expression studies demonstrated a complete lack of its expression in B6 allele carriers. (iv) Suppression of Ifi202b expression in the congenic line as well as in cells transfected with siRNA decreased the levels of 11b-Hsd1, which has previously been linked to visceral adiposity by direct evidence from transgenic and knockout mice. (v) Expression of the human IFI orthologues was affected in visceral adipose tissue of obese subjects.
Identification of Ifi202b as the causal gene crucially depends on exclusion of other sequence variations in the critical region in which we identified non-synonymous SNPs in several genes. First, Ifi202b was the only gene in the region exhibiting a significant differential expression in adipose tissue, liver and skeletal muscle associated with a structural variation. Secondly, except of Spna1-encoding for spectrin alpha 1-we failed to identify amino acid substitutions that are likely to alter protein function as classified by the Sift (Sorting intolerant from tolerant) program (22) . Thirdly, we can exclude Spna1 as responsible variant because its gene product is a major protein component of the red blood cell membrane skeleton (23) and its deficiency causes severe hereditary spherocytosis or hereditary elliptocytosis in mice (24), a phenotype not connected to obesity. However, we cannot entirely exclude that another gene in the critical region presumably together with Ifi202b participates in the induction of the adipogenic effect of Nob3.38.
The present data are the first to link the Ifi202b function with the regulation of energy balance and body weight. As a Figure 5 . Overexpression of Ifi202b suppresses other genes within the Ifi200 cluster. (A) A myc-tagged Ifi202b construct was transfected by IVE into the tibialis muscle of the right leg (TibR) of B6 mice; the left leg (TibL) was transfected with a GFP control plasmid and expression of Ifi202b and GFP was tested by western blotting. (B) Expression of the indicated transcripts was determined by qRT-PCR in tibialis muscles expressing Ifi202b-myc, and normalized for expression of b-actin. Black bars indicate expression levels of genes located in close proximity to the microdeletion but not belonging to the Ifi200 cluster (n ¼ 12) ( * P , 0.0005). downstream target of Ifi202b, we identified 11b-Hsd1 by a transcriptome analysis of adipose tissue from B6.NZONob3.38 B/B and B6.NZO-Nob3.38 N/N mice. Suppression and overexpression of Ifi202b expression in 3T3-L1 adipocytes provided direct evidence for a role of Ifi202b in the expression of 11b-Hsd1. Furthermore, direct evidence linking 11b-Hsd1 expression with obesity has been published previously: mice lacking 11b-Hsd1 are protected against the development of obesity, whereas mice overexpressing 11b-Hsd1 in adipose tissues develop visceral adiposity and insulin resistance (16, 18) . Moreover, knockdown of 11b-Hsd1 in mice by antisense oligonucleotides protected against obesity by activating thermogenesis and increasing EE (25, 26) . This phenotype is consistent with that of B6 allele carriers of B6.NZONob3.38 mice which exhibited elevated EE presumably as a consequence of increased body temperature (12) . The cortisone/cortisol system is not only involved in the stress response and inflammation but also in glucose and energy homeostasis. The enzyme 11b-Hsd1 mediates the conversion of cortisone (11-dehydrocorticosterone in rodents) to cortisol (corticosterone in rodents), locally within tissues. Thus, changes in the expression level of 11b-Hsd1 appear to contribute to altered glucocorticoid action in obesity especially when 11b-Hsd1 is elevated in adipose tissue (27) .
That the presence of Ifi202b affects body weight is also visible in recombinant congenic lines of a C57BL/6 x DBA/ 2J cross (BXD; http://www.genenetwork.org). Lines carrying the DBA/2J fragment between 175.6 Mbp (determined by rs3682996) and 176.4 Mbp (rs3669108) including the Ifi202b locus and thereby the functional Ifi202b exhibited a higher body weight (18.5 + 0.4 g) than those carrying the corresponding B6 allele (17.8 + 0.35 g) (http://www.genenetwork. org); however, this difference is not significant (P ¼ 0.257).
The Ifi200 family encodes functionally related proteins described as transcriptional modulators. Increased expression of certain Ifi200 proteins in cells is associated with inhibition of cell proliferation, modulation of apoptosis and cell differentiation (28) . Based on the finding that highest protein levels of Ifi202b were found in white adipose tissue, we suggest that this tissue plays an important role for the phenotype.
In fact, Ifi202b is differentially expressed in 3T3-L1 cells with highest levels in the preadipocytes and early time points during differentiation, indicating that Ifi202b expression might be required for the induction of adipocyte-specific transcripts. However, the increased body weight of B6. NZONob3.38 N/N mice is not only associated with increased fat but also with elevated lean mass, indicating that either targets of Ifi202b other than 11b-Hsd1 or a gene other than Ifi202b might modulate lean mass.
The fact that human orthologues of Ifi exhibit an altered expression in visceral adipose tissue of obese subjects (Fig. 8 ) support the hypothesis that Ifi genes are somehow involved in adiposity and presumably in adipose tissue function. We detected higher expression of IFI16 and MNDA in obese subjects, indicating that these two genes act in a related way to Ifi202b in the NZO mouse. Similar to the counter-regulatory effect of Ifi202b which influences expression of related transcripts, we observed that the increased expression of IFI16 and MNDA in obese individuals is associated with the suppression of another IFI gene (PYHIN1). However, since there does not exist a direct orthologue for murine Ifi202b in humans, we only can speculate that alteration of human IFI transcripts participate in the obese phenotype. As expected, the human obesity gene map (2) shows several QTL on Chr. 1 for fat intake, abdominal subcutaneous fat and BMI. Specifically, QTL for waist circumference (LOD score 3.7) and the metabolic syndrome (LOD score of 4.5) defined by the markers D1S1653-APOA2 and D1S194-D1S196, respectively, at chromosome 1q23.1 -q23.2 are located in close proximity to the IFI genes (29) .
We could prove the causal role of Ifi202b in the differential expression of the gene cluster by showing that overexpression of Ifi202b in skeletal muscle suppresses expression of related genes (Fig. 5) , whereas Ifi202b depletion in 3T3-L1 adipocytes increased expression of Ifi205, Mnda and If203 (data not shown).
In summary, our data present the identification of a microdeletion causing the disruption of Ifi202b in C57BL/6J mice which inhibits 11b-Hsd1 expression and presumably the activation of glucocorticoids in adipose tissue. It is suggested that these alterations protect from adiposity. 
MATERIALS AND METHODS
Animals
The animals were kept in accordance with the NIH guidelines for the care and use of laboratory animals, and all experiments were approved by the ethics committee of the State Agency of Environment, Health and Consumer Protection (State of Brandenburg, Germany). Female NZO mice from our own colony (NZO/HIBomDife), C57BL/6J (Charles River, Sulzfeld, Germany) and congenic lines (12) 
Breeding strategy and genotyping
Breeding of the congenic line B6.NZO-Nob3.38 was previously described (12) . Additional RCS were generated by backcrossing of male B6.NZO-Nob3.38 with 6 -12 B6 females. For genotyping, DNA was prepared from mouse tails with a DNA isolation kit based on a salt precipitation method (Invitek, Berlin, Germany) and used for tests with polymorphic microsatellite markers. Microsatellites were genotyped by PCR with oligonucleotide primers obtained from MWG (Ebersberg, Germany), and the microsatellite length was determined by non-denaturing polyacrylamide gel electrophoresis.
For further fine mapping of the critical region, SNPs were used and analysed by sequencing.
Analysis of body composition
Body weights were measured with an electronic scale. Body fat and lean mass were determined with a nuclear magnetic resonance spectrometer (Bruker Minispec instrument, Echo Medical Systems, Houston, TX, USA) as described previously (30) . . In these subjects, abdominal visceral fat area was calculated using abdominal MRI scans or computed tomography scans at the level of L4-L5. Percentage body fat was measured by dual-energy X-ray absorptiometry (DEXA). Individuals fulfilled the following exclusion criteria: (i) any acute or chronic inflammatory disease as determined by a leucocyte count . 7000 Gpt/l, C-reactive protein . 5.0 mg/dl or clinical signs of infection, (ii) detectable antibodies against glutamic acid decarboxylase, (iii) medical history of hypertension, i.e. systolic blood pressure was ,140 mmHg and diastolic blood pressure was ,85 mmHg, (iv) clinical evidence of either cardiovascular or peripheral artery disease, (v) thyroid dysfunction, (vi) alcohol or drug abuse and (vii) pregnancy. All subjects had a stable weight with fluctuations smaller than 2% of the body weight for at least 3 months before surgery. The study was approved by the ethics committee of the University of Leipzig. All subjects gave written informed consent before taking part in the study.
Total RNA was isolated from omental adipose tissue samples using TRizol (Life Technologies, Grand Island, NY, USA), and 1 mg RNA was reverse transcribed with standard reagents (Life Technologies). MNDA (Hs00935905_m1), PYHIN1 (Hs00378651_m1) and IFI16 (Hs00194261_m1) mRNA expression levels were determined by premixed assays. Samples were incubated in the ABI PRISM 7000 sequence detector for an initial denaturation at 958C for 10 min, followed by 40 PCR cycles, each cycle consisting of 958C for 15 s, 608C for 1 min and 728C for 1 min. MNDA, PYHIN1 and IFI16 mRNA expression was calculated relative to the mRNA expression of 18S rRNA, determined by a premixed assay on demand for human 18S rRNA (Applied Biosystems).
RACE PCR
Rapid amplification of cDNA ends for determination of 5
′ ends was performed with the FirstChoice RLM-RACE Kit (Ambion, Darmstadt, Germany) according to the manufacturers' instructions.
Sequencing
Sequence analysis of genes located in the critical region was done with the sequence capture technology based on the procedure described in reference (35) . Sequencing of DNA was performed with a 3130xl Genetic Analyzer (Applied Biosystems) in combination with the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Sequence analysis was done by SeqScape software 2.5 (Applied Biosystems).
Antibodies and western blotting
For the specific detection of Ifi202b, we raised a polyclonal antiserum in guinea pig against two specific peptides (1 -20: MSNRNLRSSTNSEFSEGQHQ and 336 -349: KSQNKEDS SSSDER), performed an affinity purification of the serum and used it in a dilution of 1:50 for western blotting. The antiglyceraldehyde 3-phosphate dehydrogenase antibody was purchased from Ambion (Austin, TX, USA) and used in a dilution of 1:8000 as loading control in western blots.
siRNA-mediated knockdown of Ifi202b in 3T3-L1 cells
For suppression of Ifi202b, 3T3-L1 fibroblasts (5 × 10 4 cells/ electroporation) and adipocytes (7 × 10 3 cells/electroporation) were electroporated with the Bio-Rad Gene Pulser II with settings of 170 V and 950 mF with 4 nmol Ifi202b-specific small interfering RNA (siRNA) (Mm_Ifi202b_2: 5 ′ -AAAGAUAAU GAAGAUAAUAUAUU-3 ′ , Thermo Scientific Dharmacon). For control experiments, cells were electroporated with 4 nmol non-target siRNA (5 ′ -UAGCGACUAAACACAUCA AUU-3 ′ , Thermo Scientific Dharmacon). After electroporation, cells were immediately mixed with fresh medium before being reseeded onto six-well plates. RNA was isolated 48 h after electroporation.
Overexpression of Ifi202 in 3T3-L1 adipocytes
The cDNA of Ifi202b-myc was subcloned into an adenovirus (VQAd; ViraQuest, Inc., North Liberty, IA, USA). For overexpression, VQAd-Ifi202b-myc with MOI of 100 was preincubated with 0.5 mg/ml poly-L-lysine in IMDM plus 0.5% BSA at room temperature for 100 min. Cells were washed with phosphate buffered saline (PBS) and incubated with the virus at 378C for 100 min before adding equivalent amount of IMDM/0.5% BSA for an overnight incubation. Cells were washed twice with PBS and cultured with IMDM/10% FBS for additional 72 h before harvest. As a control cells were transfected with a GFP encoding adenovirus.
Overexpression of Ifi202b in tibialis anterior
In vivo electroporation (IVE) was performed as described previously (36) . In brief, plasmids were purified using Endotoxinfree Mega-Prep kits (Qiagen), and resuspended in sterile 0.9% saline. Animals to be electroporated were anesthetized with isofluran and their hindlimbs shaved. Tibialis anterior (TA) muscles were injected with 15 units of hyaluronidase using an insulin syringe. After 60 min, animals were anesthetized again and 15 mg of Ifi202b expression plasmid (pCMVmyc-Ifi202b) in 30 ml saline was injected in the TA muscle. The contralateral muscle received injection with pEGFP vector as internal control. This was immediately followed by the application of a pair of tweezer electrodes (BTX) across the distal limb connected to an ECM-830 electroporator device (BTX). Application of eight 20 ms pulses of 80 V at a frequency of 1 Hz was used to facilitate plasmid uptake. Animals were sacrificed 7 days later and muscle rapidly dissected and shock frozen in liquid nitrogen.
Statistical analysis
Values are reported as means + SE, unless otherwise noted. Differences between B/B and N/N genotypes were tested by two-tailed Student's t-test. Statistical analysis for more than two groups was performed using two-way analysis of variance and post hoc with Scheffe's test (Statview Program, SAS Institute, Inc., Cary, NC, USA). Expression levels determined by quantitative real-time PCR were compared by the nonparametric Kruskal -Wallis H-test. A P-value ,0.05 (P , 0.05) was considered significant.
